Experience
BTG Inc., Ltd.
Actavis Labs FL Inc.and Amneal Pharms LLC
Represented BTG in PTAB proceedings and Hatch-Waxman litigation involving the block buster treatment for prostate cancer, Zytiga®.
BTG Inc., Ltd. v. Actavis Labs FL Inc.and Amneal Pharms LLC, 2:16-cv-02449, 2:16-cv-03743, 2:15-cv-05909, D.N.J., Judges McNulty, Clark
Actavis Labs FL Inc.and Amneal Pharms LLC v. BTG Inc., Ltd., IPR2016-00286, -01582, PTAB, Judges Elluru, Green, Kalan
Grünenthal GmbH et al. v. Actavis Elizabeth LLC et al.
Grünenthal GmbH
Valeant Pharmaceuticals North America, LLC v. Actavis, Inc.
Valeant Pharmaceuticals North America, LLC
Uniloc USA, Inc. et al. v. Motorola Mobility LLC et al.
Motorola Mobility LLC et al.
Finnegan secures 10 years of patent protection for Relistor®
Valeant; Salix; Progenics
Uniloc USA, Inc. et al v. Tencent America, LLC
Tencent America LLC
Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al.
Duchesnay Inc.
Amarin Pharms. Ireland Ltd. v. Omthera Pharms., Inc.
Omthera Pharmaceuticals, Inc.; AstraZeneca Pharmaceuticals LP
Valeant Pharm. N. Am. LLC and Kaken Pharm. Co. Ltd. v. Zydus Pharm. (USA) Inc.
Kaken Pharmaceutical Co., Ltd.
Global Equity Management (SA) Pt. Ltd. v. Philips Electronics North America Corp. et al.
Philips Electronics North America Corp. et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.